At 17.2x trailing earnings but only 7.9x forward earnings with a 0.7 forward PEG, the market is clearly discounting either earnings quality or balance sheet risk. The valuation implies a sharp earnings inflection next year (EPS est. $1.64), yet the Altman Z-Score of 0.2 is distress-level and cannot be ignored. A Price/Book of 1 suggests the market assigns no premium to franchise value, while a 7.00% ROE and 4.70% operating margin show mediocre profitability. This is not a clean growth story—it is a stressed regional bank priced for skepticism, and the spread between the 17.2 P/E and 7.9 forward P/E suggests either deep undervaluation or earnings volatility the market does not trust.